Argireline FAQ: common questions answered
A topical cosmetic peptide with small, mixed wrinkle studies and limited skin penetration.
Also called: Acetyl hexapeptide-8, Acetyl hexapeptide-8 amide, Acetyl hexapeptide-3 (older name), AH8, Ac-EEMQRR-NH2.
Cosmetic peptides · SNAP-25-mimicking cosmetic hexapeptide.
- Is Argireline FDA-approved? No. Cosmetic ingredient, not an FDA-approved AH8 drug. Cosmetic sale is not drug approval. No approved therapeutic indication or drug dosing label located.
- How do people take it? On the skin, twice daily. Source: reported by users, not an established dose.
- What's the difference between Argireline and GHK-Cu? Argireline: a topical cosmetic peptide with small, mixed wrinkle studies and limited skin penetration. GHK-Cu: a copper-binding skin peptide with small topical studies and untested systemic injections. Why people pair them: reported in broader skin routines; no controlled study of this reported combination was located.
- Can I take it with Copper peptides? Reported in broader skin routines; no controlled study of this reported combination was located. Added benefit and combined-product stability are unknown. Source: reported by users. Ask a doctor before combining anything.
- Is it banned in sport? It is unclear (WADA 2026). The List does not name AH8. S0 covers unapproved pharmacological substances; absence by name does not establish permission for every route.
- How do I store it once opened? Follow the finished product’s stated storage and period after opening; protect from heat and keep the container clean.
Related to Argireline
- Matrixyl: A topical cosmetic peptide with limited human evidence for making fine lines less visible.
- GHK-Cu: A copper-binding skin peptide with small topical studies and untested systemic injections.
Sources
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, FDA · FDA · 2026
- Pyrogen and Endotoxins Testing: Questions and Answers, FDA · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2025
- Consumer products: cosmetics, Office for Product Safety and Standards · 2025
- HFP Centers of Excellence 2023-24 Annual Report, FDA · 2024
- Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice, FDA · 2004
- Allergens in Cosmetics, U.S. Food and Drug Administration · FDA
- Cosmetic ingredient database, European Commission
- Cosmetics, Therapeutic Goods Administration
- Microbiological Safety and Cosmetics, U.S. Food and Drug Administration · FDA
- Notification of Cosmetics, Health Canada
- Shelf Life and Expiration Dating of Cosmetics, FDA
- Wrinkle Treatments and Other Anti-aging Products, U.S. Food and Drug Administration
- DES-mediated self-assembled polypeptides: Synergistic neuromuscular signaling inhibition for anti-aging., Bai D et al. · Biomaterials advances · 2026
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.